Health Condition 1: N711- Chronic inflammatory disease of uterus
Conditions
Interventions
Intervention1: Doxycycline: 100 mg BD for 14 Days
Intervention2: Metronidazole: 400 mg BD for 14 Days
Control Intervention1: Ciprofloxacin: 200 mg/100 ml (3 ml infusion on every 3rd day) for 30 days
C
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Positive diagnosis of Chronic endometriosis Previous IVF Failure Recurrent Pregnancy Loss (RPL) or Recurrent implantation Failure (RIF) No previous live birth FSH and LH levels evaluated on day 2 of menstrual cycle less than 12 IU/ml AMH levels greater than 1.1 ng/ml Progestrone levels evaluated on day 21 of menstrual cycle greater than 2 and less than 25 ng/ml BMI greater than 18.5 and less than 29.9
Exclusion criteria
Exclusion criteria: Diagnosed endometriosis or other related Pelvic Inflammatory Disorder (PID) Current or previous cancer diagnosis. Auto-immune, genetic or reproductive disorders. Reproductive history of pregnancy loss due to genetic abnormalities. Male factor infertility diagnosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical Pregnancy Rate (Beta HCG) and Clinical Pregnancy Rate (Gestational Sac and fetal heart sound on USG)Timepoint: 2-3 weeks after embryo transfer and 6-8 weeks post embryo transfer | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Apoorva Dave
Department of Obstetrics and Gynecology, Datta Meghe Institute of Higher Education and Research
Outcome results
None listed